Biocartis
4 known investors
Biocartis develops Idylla, a fully automated real-time PCR molecular testing system that delivers biomarker results in about three hours for oncology applications. The company targets clinical labs, oncologists, and pathologists, and runs partnership programs with pharmaceutical and diagnostic companies.
BiotechHealthtechMedical Devices